Skip to main content
Erschienen in: CEN Case Reports 3/2021

03.03.2021 | Case Report

Complete remission of DnaJ homolog subfamily B member 9-positive fibrillary glomerulonephritis following steroid monotherapy in an elderly Japanese woman

verfasst von: Takahiro Uchida, Shuuhei Komatsu, Takashi Sakai, Aki Kojima, Sachiko Iwama, Kentaro Sugisaki, Takashi Oda

Erschienen in: CEN Case Reports | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

A 74-year-old Japanese woman was referred to our department because of anasarca and massive proteinuria. She was clinically diagnosed with nephrotic syndrome, and renal biopsy showed membranoproliferative glomerulonephritis accompanied by marked glomerular infiltration with macrophages and full-house immunofluorescence glomerular deposition. Furthermore, randomly arranged nonbranching fibrils, approximately 12 nm in diameter, were found by electron microscopy, and immunostaining for DnaJ homolog subfamily B member 9 (DNAJB9), a recently identified diagnostic biomarker of fibrillary glomerulonephritis (FGN), showed positive result, thereby confirming the diagnosis of FGN. Steroid treatment was initiated, and she obtained complete remission of nephrotic syndrome and has maintained it. FGN is an uncommon form of glomerular disease, and reported cases of DNAJB9-positive FGN among Asians, particularly among Japanese population, are rare. There have been no established therapeutic regimens and its renal prognosis is generally unfavorable. The present case suggests that some patients with FGN can achieve favorable clinical outcomes through steroid monotherapy.
Literatur
Metadaten
Titel
Complete remission of DnaJ homolog subfamily B member 9-positive fibrillary glomerulonephritis following steroid monotherapy in an elderly Japanese woman
verfasst von
Takahiro Uchida
Shuuhei Komatsu
Takashi Sakai
Aki Kojima
Sachiko Iwama
Kentaro Sugisaki
Takashi Oda
Publikationsdatum
03.03.2021
Verlag
Springer Singapore
Erschienen in
CEN Case Reports / Ausgabe 3/2021
Elektronische ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-021-00585-y

Weitere Artikel der Ausgabe 3/2021

CEN Case Reports 3/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.